본문 바로가기

Targeting NEU Protein in Melanoma Cells with Non-Thermal Atmospheric Pressure Plasma and Gold Nanoparticles

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY11(5) · pp.900 · 2015
피인용
Web of Science 27
JCR IF
JCR 2014 5.338
ISSN
1550-7033

저자

  1. 최별보라제1저자부산대학교, 치의학전문대학원, 치의학과, KO
  2. Kim, Myung Soo포항공과대학교, Dept Elect & Elect Engn, KO
  3. Song, Ki Won연세대학교, Coll Life Sci & Biotechnol, Dept Biochem, KO
  4. 김욱규부산대학교, 치의학전문대학원, 치의학과, 구강악안면외과학, KO
  5. 홍진우부산대학교, 한의학전문대학원, 한의학과, 임상의학1부, KO
  6. 이해준교신저자부산대학교, 공과대학, 전기공학과, 전기공학전공, KO
  7. 김규천교신저자부산대학교, 치의학전문대학원, 치의학과, 구강해부학교실, KO

초록

Non-thermal atmospheric pressure plasma effectively kills cancer cells, but it cannot selectively kill cancer cells. The authors targeted NEU (human epidermal growth factor receptor 2) protein, which is frequently over-expressed in the cell membrane of melanoma cells, using anti-NEU antibody-labeled gold nanoparticles. The labeled nanoparticles preferentially targeted melanoma cells rather than normal keratinocytes. After the addition of labeled gold nanoparticles to melanoma and normal keratinocyte cells, both cells were exposed to non-thermal atmospheric pressure plasma. The death rate of melanoma cells was significantly higher than that of normal keratinocyte cells; many vacuoles, indicative of cell death, were observed in melanoma cells treated with anti-NEU antibody labeled gold nanoparticles and plasma. This selective cancer cell death was attributed to the selective destruction of NEU protein and a downstream effector of NEU. Our study findings show that treatment with a combination of non-thermal atmospheric pressure plasma and anti-NEU antibody-labeled gold nanoparticles effectively and selectively kills melanoma cells.

키워드

Gold NanoparticlesNon-Thermal Atmospheric Pressure PlasmaMelanomaNEUSelective Cell DeathOVARIAN-CANCER CELLSFOCAL ADHESION KINASEHER2NANOTECHNOLOGYIMMUNOTHERAPYMOTILITYTHERAPYPTPN12FAK

식별자

WoS UID
000344969800013